Is Safety Shot, Inc. overvalued or undervalued?

As of 16 August 2021, Safety Shot, Inc. has moved from a grade of does not qualify to risky, indicating a significant deterioration in its valuation outlook. The company is considered overvalued, particularly given its troubling financial ratios, including a Price to Book Value of -20.94 and an EV to EBITDA of -0.80, both of which suggest severe financial distress. Additionally, the Return on Capital Employed (ROCE) is an alarming -782.57%, reflecting inefficiencies in generating returns from capital.
In comparison to its peers, Safety Shot, Inc. stands out negatively against Olaplex Holdings, Inc., which has an attractive P/E ratio of 76.70, and Natural Health Trends Corp., which boasts a very attractive EV to EBITDA of 60.78. The stark contrast in valuation metrics underscores the challenges Safety Shot faces in the market. Furthermore, the company's stock performance has been dismal, with a year-to-date return of -54.56%, significantly lagging behind the S&P 500's gain of 2.44% during the same period.